Eastnine

Eastnine

Sälj aktien Köp aktien Handla aktien direkt på nordnet

« Tillbaka

Eastnine - Warsaw to become the largest market

14 juli 2026

  • Q2 report broadly in line with expectations
  • The Bridge deal is the largest incremental news
  • Significant earnings growth in 2027/2028e

Q2 report wrap

Eastnine's Q2 report saw rental income and NOI in line with expectations, while rec PTP was burdened by the large cash position and costs related to build-up of the organisation in Poland. The occupancy rate surprised positively and came in at 96.5% (+0.9pp q-o-q) while earnings capacity contracted sequentially on the Riga divestments, as expected.

The Bridge drives estimate revisions

As we highlighted in our fast comment last Tuesday, Eastnine has acquired The Bridge in central Warsaw with a rental value of EUR 18.2m at an underlying property value of EUR 300m. The occupancy rate is 92% and the deal will be financed with existing cash, new debt, and refinancings of the existing portfolio. We understand that the purchase price of EUR 260m is lower than the property value of EUR 300m due to remaining tenant adaptations (~EUR 15m), deductions for initial vacancies (e.g. Visa will move in during 2027) and rental discounts. Management sounds confident that the letting ratio will surpass the current 92% at completion (Q4'26e), but tenants will move in gradually, meaning that the reported occupancy will come down initially while the full effect from the acquisition will only start to show in 2028e.

Prime assets but with high yields

Unlike the Swedish office market, Eastnine's core markets are seeing strong GDP growth, low office vacancies and positive rent reversion. Supply growth is falling and demand remains solid. We expect this to fuel stronger like-for-like rental income growth than Swedish peers, and significantly better cash flow, especially after maintenance capex. At a normalised cash ROE (CEPS/EPRA NRV) of ~6.7%, the returns are more comparable to Swedish industrial companies (Catena/Sagax/SLP at ~7%) than office companies (Atrium Ljungberg, Fabege, Hufvudstaden at ~3%), but with prime CBD assets.

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-07-15 Infrea - Strong quarter but pegged to Netel Infrea Analys
2026-07-15 Coor - Solid earnings despite softer sales Coor Analys
2026-07-15 Svedbergs Group - Nordics and one-offs weigh Svedbergs G.. Analys
2026-07-14 Nexam Chemical - Solid Q2, profitability within r... Nexam Chemical Analys
2026-07-14 Nexam Chemical - Record sales and first positive ... Nexam Chemical Analys
2026-07-14 Eastnine - Warsaw to become the largest market Eastnine Analys
2026-07-13 Ascelia Pharma - CRL update Ascelia Pharma Analys
2026-07-13 Medicover - Steady as she goes Medicover Analys
2026-07-13 Arctic Paper - Pulp beats paper Arctic Paper Analys
2026-07-13 Studsvik - Gearing up for the new-build era Studsvik Analys
2026-07-10 StrongPoint - The American dream StrongPoint Analys
2026-07-10 Careium - The pressure valve starting to open Careium Analys
2026-07-10 StrongPoint - Solid Q2 performance StrongPoint Analys
2026-07-10 Careium - Growth's comeback tour continues Careium Analys
2026-07-09 Infrea - Road tripping with Netel Infrea Analys
2026-07-08 Alligo - Softer growth, but margin recovery conti... Alligo Analys
2026-07-08 Qliro - Key earnings drivers intact Qliro Analys
2026-07-07 Nexam Chemical - We expect a firmer sequential qu... Nexam Chemical Analys
2026-07-07 Eastnine - Adding in Warsaw Eastnine Analys
2026-07-06 Ovzon - No Q2 fireworks, but plenty of fuel Ovzon Analys